On October 7, a compounding trade group filed a lawsuit challenging the agency's action, saying there was still a shortage of the wildly popular drug.
The change will expand access to the diabetes and weight-loss drugs. But it will also complicate the future of compounded ...
Pharmacists can continue making compounded versions of generic tirzepatide, the active ingredient in popular medications ...
The reconsideration follows an Oct. 11 lawsuit that prompted U.S. District Judge Mark Pittman to temporarily halt legal proceedings to give the FDA time to reassess its ruling.
The FDA is weighing a decision that could stop compounding pharmacies from legally making cheaper versions of Mounjaro and ...
After nearly two years, federal regulators announced the shortage of the active ingredient in Mounjaro and Zepbound has ...
The agency agreed in court to allow compounding companies to continue producing copycat versions of Lilly’s fast-selling ...
It was the insistent questioning of my four-year-old grandson that goaded me into it. “Why is your tummy so big” he asked ...
A trade organization representing compounding pharmacies that make unbranded versions of the weight loss drugs Mounjaro and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback